Siblings Books/Book Section [4/5] Conference Papers/Meeting Abstract [3/4] Patents [0/44] Collection Statistics Item counts issued in 3 years:2(2.00%) Items With Fulltext:97(97.00%) Download counts of the item Download times greater than 0:97(100.00%) Download times greater than 100:97(100.00%) Total Bitstream Download Counts:67232(94.66%) Last Update: 2024-12-01 10:01 Top Upload Loading... Top Download Loading... Recent Submissions Propagation and immunological chara... The uncoating of EV71 in mature lat... Polysorbasome: A colloidal vesicle ... Enhancing enterovirus A71 vaccine p... Degradable emulsion as vaccine adju... Development of a full-length cDNA-d... Immunogenicity of a novel tetravale... Mucosal delivery of a combination a... Immunological and biochemical chara... The successful induction of T-cell ...

Jump to a point in the index: (Choose year) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (Choose month) January February March April May June July August September October November December Or type in a year:

Ordering With Most Recent First Show Oldest First

Showing items 26-50 of 100. (4 Page(s) Totally) << < 1 2 3 4 > >> View [10|25|50] records per page

Date	Title	Relation
2014-08-27	Delivery of human EV71 receptors by adeno-associated virus increases EV71 infection-induced local inflammation in adult mice	BioMed Research International. 2014 Aug 27;2014:Article number 878139.
2014-07-30	Toll-like receptor 9-mediated protection of enterovirus 71 infection in mice is due to the release of danger-associated molecular patterns	Journal of Virology. 2014 Jul 30;88(20):11658-11670.
2014-06-11	Immunogenicity studies of bivalent Inactivated virions of EV71/CVA16 formulated with submicron emulsion systems	Biomed Research International. 2014 Jun 11;2014:Article number 670506.
2014-05	Molecular mechanisms of TLR2-mediated antigen cross-presentation in dendritic cells	Journal of Immunology. 2014 May;192(9):4233-4241.
2014-03	Recombinant lipidated dengue-4 envelope protein domain III elicits protective immunity	Vaccine. 2014 Mar;32(12):1346-1353.
2014-03	A purified recombinant lipopeptide as adjuvant for cancer immunotherapy	BioMed Research International. 2014 Mar;2014:Article number 349783.
2014-01	A novel emulsion-type adjuvant containing CpG oligodeoxynucleotides enhances CD8+ T-cell-mediated anti-tumor immunity	Journal of Controlled Release. 2014 Jan;173(1):158-165.
2014-01	Disintegration and cancer immunotherapy efficacy of a squalane-in-water delivery system emulsified by bioresorbable poly(ethylene glycol)-block-polylactide	Biomaterials. 2014 Jan;35(5):1686-1695.
2013-12	The Madin-Darby canine kidney cell culture derived influenza A/H5N1 vaccine: A Phase I trial in Taiwan	Journal of Microbiology, Immunology and Infection. 2013 Dec;46(6):448-455.
2013-11-21	Formalin-inactivated EV71 vaccine candidate induced cross-neutralizing antibody against subgenotypes B1, B4, B5 and C4A in adult volunteers	PLoS ONE. 2013 Nov 21;8(11):Article number e79783.
2013-11	Formulation and immunological evaluation of a trivalent vaccine comprising emulsified submicron particles and inactivated virions of H5N1/EV71/JEV	Human Vaccines and Immunotherapeutics. 2013 Nov ;9(11):2378-2385.
2013-09-19	Lipidated dengue-2 envelope protein domain III independently stimulates long-lasting neutralizing antibodies and reduces the risk of antibody-dependent enhancement	PLoS Neglected Tropical Diseases. 2013 Sep 19;7(9):Article number e2432.
2013-09	Induction of robust immunity by the emulsification of recombinant lipidated dengue-1 envelope protein domain III	Microbes and Infection. 2013 Sep;15(10-11):719-728.
2013-07-30	Protective efficacy of VP1-specific neutralizing antibody associated with a reduction of viral load and pro-inflammatory cytokines in human SCARB2-transgenic mice	PLoS ONE. 2013 Jul 30;8(7):Article number e69858.
2013-07	A consensus envelope protein domain III can induce neutralizing antibody responses against serotype 2 of dengue virus in non-human primates	Archives of Virology. 2013 Jul;158(7):1523-1531.
2013-06-13	Enzymatic stability and immunoregulatory efficacy of a synthetic indolicidin analogue with regular enantiomeric sequence	ACS Medicinal Chemistry Letters. 2013 Jun 13;4(6):522-526.
2013-05	A Phase I, randomized, open-label study to evaluate the safety and immunogenicity of an enterovirus 71 vaccine	Vaccine. 2013 May;31(20):2471-2476.
2013-05	Mesenchymal stem cells tune the development of monocyte-derived dendritic cells toward a myeloid-derived suppressive phenotype through growth-regulated oncogene chemokines	Journal of Immunology. 2013 May;190(10):5065-5077.
2013-02-25	Human SCARB2 transgenic mice as an infectious animal model for Enterovirus 71	PLoS ONE. 2013 Feb 25;8(2):Article number e57591.
2013-01	Mesenchymal stem cells promote neutrophil activation by inducing IL-17 production in CD4+ CD45RO+ T cells	Immunobiology. 2013 Jan;218(1):90-95.
2012-12	Production of EV71 vaccine candidates	Human Vaccine Immunotherapy. 2012 Dec;8(12):1775-1783.
2012-11-30	Immunological and biochemical characterization of Coxsackie Virus A16 viral particles	PLoS ONE. 2012 Nov 30;7(11):Article number e49973.
2012-09	Immunological evaluation and comparison of different EV71 vaccine candidates	Clinical and Developmental Immunology. 2012 Sep;2012:Article ID 831282.
2012-08-28	Challenges to licensure of enterovirus 71 vaccines	PLoS Neglected Tropical Diseases. 2012 Aug 28;6(8):Article number e1737.
2012-08	CD4+ T cells disarm or delete cytotoxic T lymphocytes under IL-17–Polarizing conditions	Journal of Immunology. 2012 Aug;189(4):1671-1679.

Showing items 26-50 of 100. (4 Page(s) Totally) << < 1 2 3 4 > >> View [10|25|50] records per page